We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore brachytherapy, an advanced internal radiation technique for cervical cancer. Learn about the procedure, its effectiveness compared to external radiation, potential side effects, and recovery.
Cervical cancer, a significant health concern for women globally, requires advanced treatment strategies. Among these, brachytherapy, a form of internal radiation therapy, stands out as a potent weapon. It's often used alongside external beam radiation therapy (EBRT) to deliver a high dose of radiation directly to the cancerous cells in the cervix, uterus, or vagina, while minimizing exposure to surrounding healthy tissues. This targeted approach capitalizes on the inverse square law, where radiation intensity drops sharply with distance from the source. Imagine a spotlight precisely illuminating a tumor while leaving the rest of the stage in relative darkness – that’s the essence of brachytherapy’s precision.
For context, cervical cancer ranks as the fourth most common cancer among women worldwide. In India, it remains a leading cause of cancer-related deaths in women, underscoring the critical need for effective treatment modalities. While statistics from the US mention around 14,480 new diagnoses annually, the burden in India is substantial, with lack of awareness and access to screening contributing to later-stage diagnoses. Brachytherapy offers a beacon of hope, especially in cases where other treatments might be less effective or tolerated.
It's essential to understand how brachytherapy differs from EBRT. EBRT, as the name suggests, delivers radiation from a source outside the body using a machine. Think of it as a broad floodlight. This treatment is generally painless, requires a few minutes per session, and is often administered over several outpatient visits. EBRT can be a primary treatment option for some women, particularly if they cannot tolerate chemotherapy or opt against surgery. It's frequently used in conjunction with chemotherapy and, importantly, with brachytherapy.
Brachytherapy, however, is internal. An implant, also called an applicator, is placed directly within or very near the cancerous site – in the cervix, uterus, or vagina for cervical cancer. Radioactive material is then carefully loaded into this applicator. This allows for a much higher concentration of radiation to be delivered to the tumor compared to what’s possible with EBRT alone. Studies have shown remarkable results: a 2017 study involving 220 women with cervical cancer found that those receiving both EBRT and brachytherapy had a 92.5% tumor remission rate, compared to 73.3% with EBRT alone. The 5-year survival rate also saw a significant jump, from 35.4% to 68.5%. Furthermore, cancer recurrence rates were lower in the group that received brachytherapy.
A 2021 study reinforced these findings, examining over 2,300 women with metastatic cervical cancer. It confirmed that brachytherapy, whether used alone or with EBRT, significantly boosted survival rates. This evidence highlights brachytherapy’s indispensable role in managing advanced cervical cancer.
The brachytherapy procedure itself requires careful planning and execution. Before the treatment begins, your doctor will perform a physical examination and may order imaging tests like CT or MRI scans to precisely map the tumor and surrounding anatomy. This helps in determining the best type of applicator and its placement.
The applicator, often a small, hollow tube or a mold, is inserted into the cervix, uterus, or vagina. The exact placement depends on the tumor's size, location, and your individual pelvic anatomy. If the uterus is involved, different applicator designs might be used to ensure optimal coverage. This procedure is typically done under anesthesia, either local or general, to ensure your comfort. You might feel some pressure or discomfort, but pain is usually managed effectively.
Once the applicator is in place, radioactive sources (like seeds, wires, or pellets) are carefully inserted into the applicator. These sources emit radiation that targets and damages cancer cells. The duration of radiation delivery varies, from a few minutes to several hours or even days, depending on the type of brachytherapy (low-dose rate or high-dose rate) and the prescribed radiation dose. High-dose rate (HDR) brachytherapy, which is common for cervical cancer, involves delivering high doses of radiation over short periods, with the sources removed after each session. Low-dose rate (LDR) brachytherapy involves leaving the radioactive material in place for a longer duration, sometimes days, with the sources being removed permanently or temporarily.
After the radiation is delivered, the applicator is removed. You might need to stay in the hospital for a short period, especially with LDR brachytherapy, to ensure radiation levels are safe before you go home. For HDR brachytherapy, patients are often discharged the same day or the next morning.
Like any medical treatment, brachytherapy can cause side effects. These are generally related to the radiation’s effect on nearby tissues in the pelvis. Common side effects include:
It's vital to communicate any side effects you experience to your healthcare team. They can offer strategies and treatments to manage discomfort and improve your quality of life during and after treatment.
Recovery from brachytherapy is a gradual process. After treatment, you'll likely have regular follow-up appointments with your oncologist. These visits are crucial for monitoring your recovery, checking for any recurrence, and managing any lingering side effects. Your doctor will advise on when it's safe to resume normal activities, including work, exercise, and sexual intimacy.
Vaginal dilation exercises may be recommended to maintain vaginal elasticity and prevent narrowing, especially if radiation has affected the vaginal tissues. Your doctor will guide you on the frequency and technique for these exercises.
The long-term outlook for cervical cancer patients treated with brachytherapy is generally positive, particularly when the cancer is detected early. The success rates, as evidenced by the studies mentioned earlier, are encouraging. However, it’s important to remember that individual outcomes can vary based on the stage of cancer, the patient's overall health, and their response to treatment.
It is imperative to seek medical attention if you experience any of the following:
Regular screening with Pap smears and HPV tests is your first line of defense. If you have any concerns about your reproductive health, do not hesitate to speak with your gynecologist or a general physician.
The procedure is usually performed under anesthesia to minimize discomfort. You might feel pressure during the insertion of the applicator. Post-treatment, some soreness is common but usually manageable with medication. Your medical team prioritizes your comfort.
The duration varies. High-dose rate (HDR) brachytherapy sessions are short, but you might have multiple sessions over days or weeks. Low-dose rate (LDR) brachytherapy involves leaving the source in place for longer periods, from hours to days. Your doctor will provide a specific timeline.
For some women, fertility may be affected. Discuss your family planning goals with your doctor before treatment. Depending on the stage and type of treatment, options like egg freezing might be considered. Some women may still be able to conceive, but pregnancy after cervical cancer treatment requires careful medical supervision.
If you receive LDR brachytherapy where the source remains in place, you might need to limit contact with others for a period to minimize their radiation exposure. For HDR, once the source is removed, there are generally no specific radiation precautions needed. Your doctor will provide detailed instructions.
Brachytherapy is a cornerstone treatment, especially for locally advanced cervical cancer, often used in combination with EBRT and chemotherapy. Its effectiveness can depend on the stage, but it plays a vital role in improving outcomes for many women.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026